HEALTH NEWS
Moderna: Covid-19 vaccine protection wanes
In a news release, the Moderna said that the new data from Moderna Inc’s (MRNA.O) large Covid-19 vaccine trial shows that the protection it offers wanes over time, supporting the case for booster doses.
“This is only one estimate, but we do believe this means as you look toward the fall and winter, at minimum we expect the estimated impact of waning immunity would be 600,000 additional cases of Covid-19,” Moderna President Stephen Hoge said on a conference call with investors.
He added, “We believe this will reduce Covid-19 cases.”
Hoge further stated, “We also believe that a third dose of mRNA-1273 has a chance of significantly extending immunity throughout much of next year as we attempt to end the pandemic.”